UNCLASSIFIED THERAPEUTIC AGENTS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
LEVODOPA & CARBIDOPA: products 21 to 25 of 25.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Sinemet CR 100mg & 25mg CR TabDIN 02028786 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Sinemet CR 200mg & 50mg CR TabDIN 00870935 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Teva-Levocarbidopa 100mg & 10mg TabDIN 02244494 | General benefit | $0.1479per source unit | Requirements & sourcesBuild cost plan |
| Teva-Levocarbidopa 100mg & 25mg TabDIN 02244495 | General benefit | $0.2209per source unit | Requirements & sourcesBuild cost plan |
| Teva-Levocarbidopa 250mg & 25mg TabDIN 02244496 | General benefit | $0.2466per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
92:00 UNCLASSIFIED THERAPEUTIC AGENTS.
92:20 Biologic Response Modifiers.
92:36 Disease-Modifying Antirheumatic Agents.
92:44 Immunosuppressive Agents.
92:92 Other Miscellaneous Therapeutic Agents.